On October 12, the European Union Published the following Commission Regulations amending MRLs for several active substances:
- Reg. (EU) 2018/1514 regarding abamectin, acibenzolar-S-methyl, clopyralid, emamectin, fenhexamid, fenpyrazamine, fluazifop-P, isofetamid, Pasteuria nishizawae Pn1, talc E553B, and tebuconazole in or on certain products.
- Reg. (EU) 2018/1515 regarding diphenylamine and oxadixyl in or on certain products.
- Reg. (EU) 2018/1516 regarding penoxsulam, triflumizole, and triflumuron in or on certain products.
Amended MRLs go into effect November 1, 2018 (Reg. 2018/1514) and May 1, 2019 (Reg. 2018/1515 and Reg. 2018/1516). Relevant pending MRL changes will be available in the Global MRL Database on October 16, 2018.